Business Standard

Abbott's Korea-imported PanBio Covid-19 self test launched at Rs 325

Firm expects demand from both, institutions and retail consumers, will import kits in 4-pack sizes from Korean plant; Test linked with NAVICA app which uploads results on ICMR website

PanBio Covid test

The results come in 15 minutes, and the test is to be used along with Abbott’s NAVICA mobile app

Sohini Das Mumbai
With the Covid-19 self-testing landscape maturing in India, US-based pharma and diagnostics giant Abbott launched Panbio has launched a rapid antigen self-test kit in India for Rs 325 a test. This is the second such test kit available in the country after Pune-based Mylab Discovery Solutions launched CoviSelf in May.

CoviSelf is priced at Rs 250 per test.

Abbott’s Panbio, which will be imported from its Korean plant, will be available at retail outlets by the end of this month. Ambati Venu, Vice President, Pharmaceuticals, Abbott India said that compared to an RT-PCR test, this is much more economical, and

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 12 2021 | 5:48 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to